Press Releases |

23.02.2022

BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting

Finance

Show Article

02.02.2022

AnalytiCon Discovery and Pharvaris extend their collaboration

Corporate Technology

Show Article

01.02.2022

BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business

Corporate

Show Article

17.01.2022

BRAIN Biotech AG publishes Annual Report for FY 2020/21

Finance Corporate

Show Article

11.01.2022

BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology

Technology Corporate

Show Article

08.12.2021

Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)

Technology

Show Article

03.11.2021

BRAIN and SAMS apply BEC gene-editing technology to Omega-3 Compounds from Marine Organisms

Technology Corporate

Show Article

15.09.2021

BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives

Corporate Finance

Show Article

03.09.2021

Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential

Corporate

Show Article